Login
$RIGL
$43.73 -$0.73 (1.64%) Live

$RIGL 8-K/A SEC Filings

Filed On Filing
18 Sep 2009 8-K/A: Financial Statements and Exhibits

You have requested our opinion with respect to certain matters in connection with the sale by Rigel Pharmaceuticals, Inc. (the “Company”), of up to 14,950,000 shares of the Company’s common stock, par value $0.001 per share (the “Shares”...

14 Nov 2005 8-K/A: Departure/Election of Directors or Officers; Compensation

On October 6, 2005, Rigel Pharmaceuticals, Inc. filed a Current Report on Form 8-K to report that Gary A. Lyons, was appointed to serve on Rigel’s Board of Directors. At the time of his appointment, the Board of Directors had not yet det...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support